Advertisement


Marie A. Flannery, PhD, and Eva Culakova, PhD, on Managing Symptoms in Older Adults With Advanced Cancer

2020 ASCO Quality Care Symposium

Advertisement

Marie A. Flannery, PhD, and Eva Culakova, PhD, both of the University of Rochester, discuss a geriatric assessment tool that helped reduce symptomatic toxicities, as measured by Patient-Reported Outcomes Common Terminology Criteria for Adverse Events (Abstract 138).



Related Videos

Issues in Oncology
Pain Management

James D. Murphy, MD, on Opioid Use Among Patients With Cancer

James D. Murphy, MD, of the University of California, San Diego, discusses the possible reasons for a decline in long-term opioid use in patients with cancer, even as short-term use is rising, as well as the racial and socioeconomic disparities of opioid use in this population (Abstract 187).

Issues in Oncology

Katherine Enright, MD, MPH, on Improving the Quality of Oral Cancer Drug Delivery

Katherine Enright, MD, MPH, of Trillium Health Partners in Ontario, discusses a model of quality improvement, which potentially could be adapted across health systems to improve oral systemic cancer care (Abstract 184).

Issues in Oncology

Cardinale B. Smith, MD, PhD, on Redesigning Care Coordination From the Patient’s Perspective

Cardinale B. Smith, MD, PhD, of the Icahn School of Medicine at Mount Sinai, discusses results of a pilot study suggesting dedicated lay staff members, who facilitated admissions and discharges for patients with cancer across care settings, could improve health-care utilization, quality, and the patient experience (Abstract 6).

Breast Cancer
COVID-19

Melissa K. Accordino, MD, on Breast Cancer Care Delivery: Impact of the COVID-19 Pandemic

Melissa K. Accordino, MD, of Columbia University Medical Center, discusses findings showing nearly half of the patients with breast cancer treated at an academic center in New York City experienced a change or delay in their workup or treatment during the COVID-19 pandemic. Race and socioeconomic factors played a significant role (Abstract 88).

Issues in Oncology

Joseph M. Unger, PhD, on Patient Interest in Clinical Trial Enrollment: A New Analysis

Joseph M. Unger, PhD, of Fred Hutchinson Cancer Research Center, discusses study results showing that more than half of all patients with cancer, regardless of race or ethnicity, agree to take part in clinical trials, a finding that upends conventional beliefs. He talks about removing the barriers to help more patients participate (Abstract 92).

Advertisement

Advertisement




Advertisement